EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a High-Sensitivity Multiplex mRNA-Based KIT D816V Droplet Digital PCR Assay and Correlation with Tumor Load in Systemic Mastocytosis

Abdulrazzaq Alheraky iD, Arjan Simpelaar, Lucy B Hesp, Albertus T J Wierenga iD, Moniek Heddema, Isidor Minović iD, Saskia K Klein iD, Hanneke N G Oude Elberink iD, Ido P Kema, André B Mulder

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27146314 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Abdulrazzaq Alheraky und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, P.O. Box 30001, 9700 RB Groningen, The Netherlands. Hauptthemen laut MEDLINE: Mastocytosis, Systemic, Proto-Oncogene Proteins c-kit, RNA, Messenger, Multiplex Polymerase Chain Reaction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Detecting a KIT D816V mutation in patients with systemic mastocytosis (SM) needs a high-sensitivity assay. Additionally, high mutant KIT transcriptional activity and multilineage involvement are strong unfavorable prognostic parameters in SM. The current frequently used quantitative PCR-based KIT D816V assays have important analytical limitations, including considerable analytical variation in the low-concentration range, a need for a calibration curve, less multiplexing capabilities, and higher susceptibility to interference by PCR inhibitors. We developed, validated, and explored the diagnostic relevance of a novel multiplex KIT D816V cDNA droplet digital PCR (ddPCR), using ABL1 and KIT as reference genes. Furthermore, we correlated the expressed allele burden (EAB) with variant allele frequency (VAF) and percentage of neoplastic mast cells (nMC%) in bone marrow samples of 79 SM patients. Our assay shows very low background signals and high assay precision, leading to a linear dynamic range spanning five orders of magnitude and very low limits of detection and quantification of 0.062% (EAB/ABL1) and 0.027% (EAB/KIT). The assay detects median 57 times more mutant cDNA copies than mutant gDNA copies in SM patients and positivity in 83% of SM-suspected patients with negative gDNA ddPCR results. Furthermore, correlations between EAB, VAF, and nMC% suggest the presence of KIT D816V in non-MCs, either with or without transcriptional activity. Using our novel high-sensitivity mRNA-based multiplex ddPCR KIT D816V assay returns high diagnostic yield in patients with suspicion for SM. We recommend incorporating our assay in routine SM diagnostics to determine low-burden KIT D816V.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mastocytosis, SystemicProto-Oncogene Proteins c-kitRNA, MessengerMultiplex Polymerase Chain ReactionHumansMast CellsMutationGene FrequencySensitivity and SpecificityProto-Oncogene Proteins c-abl

Stichwörter der Autor:innen

KIT D816Vdroplet digital PCRflowcytometrymast cellsystemic mastocytosistranscriptional activitytumor loadvariant allele frequency

Substanzen

Proto-Oncogene Proteins c-kitRNA, MessengerKIT protein, humanProto-Oncogene Proteins c-abl

Autor:innen und Institutionen

  • Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, P.O. Box 30001, 9700 RB Groningen, The Netherlands.
  • Department of Hematology, University Medical Center Groningen, University of Groningen, P.O. Box 30001, 9700 RB Groningen, The Netherlands.
  • Department of Allergology, University Medical Center Groningen, University of Groningen, P.O. Box 30001, 9700 RB Groningen, The Netherlands.
  • Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, P.O. Box 30001, 9700 RB Groningen, The Netherlands.

ORCID-Profile: Abdulrazzaq Alheraky, Albertus T J Wierenga, Isidor Minović, Saskia K Klein, Hanneke N G Oude Elberink

Zitieren

APA

Alheraky, A., Simpelaar, A., Hesp, L. B., Wierenga, A. T. J., Heddema, M., Minović, I., Klein, S. K., Oude Elberink, H. N. G., Kema, I. P., & Mulder, A. B. (2026). Development of a High-Sensitivity Multiplex mRNA-Based KIT D816V Droplet Digital PCR Assay and Correlation with Tumor Load in Systemic Mastocytosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27146314

Vancouver

Alheraky A, Simpelaar A, Hesp LB, Wierenga ATJ, Heddema M, Minović I, et al. Development of a High-Sensitivity Multiplex mRNA-Based KIT D816V Droplet Digital PCR Assay and Correlation with Tumor Load in Systemic Mastocytosis. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27146314

BibTeX
@article{Alheraky2026,
  author = {Alheraky, Abdulrazzaq and Simpelaar, Arjan and Hesp, Lucy B and Wierenga, Albertus T J and Heddema, Moniek and Minović, Isidor and Klein, Saskia K and Oude Elberink, Hanneke N G and Kema, Ido P and Mulder, André B},
  title = {Development of a High-Sensitivity Multiplex mRNA-Based KIT D816V Droplet Digital PCR Assay and Correlation with Tumor Load in Systemic Mastocytosis},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27146314}
}
Kostenlos starten →